Transitional cell carcinoma of the bladder: Racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)

Katherine Mallin, Kevin David, Peter R. Carroll, Matthew I. Milowsky, David M. Nanus

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: Bladder cancer survival is consistently lower in female and black patients than in male and white patients. We compared trends and differences according to clinical, demographic and facility characteristics by patient race and gender to identify the impact of these characteristics on survival. Materials and Methods: We identified bladder transitional cell carcinoma cases diagnosed in 1993 to 2007 from the National Cancer Data Base. Trends in grade and stage distribution between 1993 and 2007 were analyzed. Survival differences by race and gender were compared using 5-year relative survival and multivariate Cox regression. Results: There were 310,257 white male, 102,345 white female, 13,313 black male and 7,439 black female patients. Black and female patients had a higher proportion of muscle invasive tumors than white and male patients, and black patients had a larger proportion of higher grade tumors. The incidence of stage 0a and of high grade tumors significantly increased with time. Multivariate analysis showed a significantly lower HR in white females than in white males (HR 0.9) but a significantly higher HR in black males and females (HR 1.2). The higher mortality risk in black males and females was primarily limited to late stage disease (HR 1.3). Conclusions: Survival differences by race and gender are partially explained by differences in tumor and demographic characteristics in black males and females, and fully explained by these characteristics in white females. Treatment delays and under treatment due to comorbid conditions, age and other factors may also contribute to these disparities.

Original languageEnglish (US)
Pages (from-to)1631-1636
Number of pages6
JournalJournal of Urology
Volume185
Issue number5
DOIs
StatePublished - May 1 2011

Fingerprint

Transitional Cell Carcinoma
Urinary Bladder
Survival
Neoplasms
Demography
Age Factors
Urinary Bladder Neoplasms
Multivariate Analysis
Databases
Muscles
Mortality
Incidence
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Mallin, Katherine ; David, Kevin ; Carroll, Peter R. ; Milowsky, Matthew I. ; Nanus, David M. / Transitional cell carcinoma of the bladder : Racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). In: Journal of Urology. 2011 ; Vol. 185, No. 5. pp. 1631-1636.
@article{bcba53b7a7604d5fa8f980421253795e,
title = "Transitional cell carcinoma of the bladder: Racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)",
abstract = "Purpose: Bladder cancer survival is consistently lower in female and black patients than in male and white patients. We compared trends and differences according to clinical, demographic and facility characteristics by patient race and gender to identify the impact of these characteristics on survival. Materials and Methods: We identified bladder transitional cell carcinoma cases diagnosed in 1993 to 2007 from the National Cancer Data Base. Trends in grade and stage distribution between 1993 and 2007 were analyzed. Survival differences by race and gender were compared using 5-year relative survival and multivariate Cox regression. Results: There were 310,257 white male, 102,345 white female, 13,313 black male and 7,439 black female patients. Black and female patients had a higher proportion of muscle invasive tumors than white and male patients, and black patients had a larger proportion of higher grade tumors. The incidence of stage 0a and of high grade tumors significantly increased with time. Multivariate analysis showed a significantly lower HR in white females than in white males (HR 0.9) but a significantly higher HR in black males and females (HR 1.2). The higher mortality risk in black males and females was primarily limited to late stage disease (HR 1.3). Conclusions: Survival differences by race and gender are partially explained by differences in tumor and demographic characteristics in black males and females, and fully explained by these characteristics in white females. Treatment delays and under treatment due to comorbid conditions, age and other factors may also contribute to these disparities.",
author = "Katherine Mallin and Kevin David and Carroll, {Peter R.} and Milowsky, {Matthew I.} and Nanus, {David M.}",
year = "2011",
month = "5",
day = "1",
doi = "https://doi.org/10.1016/j.juro.2010.12.049",
language = "English (US)",
volume = "185",
pages = "1631--1636",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

Transitional cell carcinoma of the bladder : Racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). / Mallin, Katherine; David, Kevin; Carroll, Peter R.; Milowsky, Matthew I.; Nanus, David M.

In: Journal of Urology, Vol. 185, No. 5, 01.05.2011, p. 1631-1636.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transitional cell carcinoma of the bladder

T2 - Racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)

AU - Mallin, Katherine

AU - David, Kevin

AU - Carroll, Peter R.

AU - Milowsky, Matthew I.

AU - Nanus, David M.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Purpose: Bladder cancer survival is consistently lower in female and black patients than in male and white patients. We compared trends and differences according to clinical, demographic and facility characteristics by patient race and gender to identify the impact of these characteristics on survival. Materials and Methods: We identified bladder transitional cell carcinoma cases diagnosed in 1993 to 2007 from the National Cancer Data Base. Trends in grade and stage distribution between 1993 and 2007 were analyzed. Survival differences by race and gender were compared using 5-year relative survival and multivariate Cox regression. Results: There were 310,257 white male, 102,345 white female, 13,313 black male and 7,439 black female patients. Black and female patients had a higher proportion of muscle invasive tumors than white and male patients, and black patients had a larger proportion of higher grade tumors. The incidence of stage 0a and of high grade tumors significantly increased with time. Multivariate analysis showed a significantly lower HR in white females than in white males (HR 0.9) but a significantly higher HR in black males and females (HR 1.2). The higher mortality risk in black males and females was primarily limited to late stage disease (HR 1.3). Conclusions: Survival differences by race and gender are partially explained by differences in tumor and demographic characteristics in black males and females, and fully explained by these characteristics in white females. Treatment delays and under treatment due to comorbid conditions, age and other factors may also contribute to these disparities.

AB - Purpose: Bladder cancer survival is consistently lower in female and black patients than in male and white patients. We compared trends and differences according to clinical, demographic and facility characteristics by patient race and gender to identify the impact of these characteristics on survival. Materials and Methods: We identified bladder transitional cell carcinoma cases diagnosed in 1993 to 2007 from the National Cancer Data Base. Trends in grade and stage distribution between 1993 and 2007 were analyzed. Survival differences by race and gender were compared using 5-year relative survival and multivariate Cox regression. Results: There were 310,257 white male, 102,345 white female, 13,313 black male and 7,439 black female patients. Black and female patients had a higher proportion of muscle invasive tumors than white and male patients, and black patients had a larger proportion of higher grade tumors. The incidence of stage 0a and of high grade tumors significantly increased with time. Multivariate analysis showed a significantly lower HR in white females than in white males (HR 0.9) but a significantly higher HR in black males and females (HR 1.2). The higher mortality risk in black males and females was primarily limited to late stage disease (HR 1.3). Conclusions: Survival differences by race and gender are partially explained by differences in tumor and demographic characteristics in black males and females, and fully explained by these characteristics in white females. Treatment delays and under treatment due to comorbid conditions, age and other factors may also contribute to these disparities.

UR - http://www.scopus.com/inward/record.url?scp=79953798532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953798532&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.juro.2010.12.049

DO - https://doi.org/10.1016/j.juro.2010.12.049

M3 - Article

C2 - 21419456

VL - 185

SP - 1631

EP - 1636

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -